January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Lung Cancer's Paradox: Never-Smokers Outlive Smokers?

New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.

Conexiant

January 15, 2025

FDA Proposes Nicotine Limits for Tobacco

The US Food and Drug Administration has introduced a proposal to cap nicotine levels in cigarettes, with the goal of curbing addiction, reducing smoking rates, and averting millions of tobacco-related deaths by 2100.

Conexiant

January 13, 2025

7-Day Antibiotic Course Matches 14 Days for Bloodstream Infections

7-day antibiotics noninferior to 14 days for bloodstream infections, reducing exposure and antibiotic-related risks.

Conexiant

January 09, 2025

Impaired Lung Function Linked to Gout

Patients with impaired lung function face up to double the gout prevalence—explore the inflammatory pathways driving this connection.

Conexiant

January 06, 2025

Low Birth Weight, Maternal Smoking Raise COPD Risk

‘The lowest birth weight group faced a 21% higher COPD risk,’ researchers reveal.

Conexiant

December 13, 2024

New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

August 22, 2024

Chronic Cough's Double-Edged Sword

Study reveals chronic cough patients were twice as likely to receive opioid-containing cough suppressants, with 21% receiving prescriptions within a year of diagnosis.

Conexiant